These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37665256)

  • 1. [Several heart conditions are related to increased risk of ischemic stroke and TIA].
    G Lindgren A; Wester P
    Lakartidningen; 2023 Sep; 120():. PubMed ID: 37665256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Cardioembolic Stroke.
    Yaghi S
    Continuum (Minneap Minn); 2023 Apr; 29(2):462-485. PubMed ID: 37039405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.
    Ntaios G; Papavasileiou V; Sagris D; Makaritsis K; Vemmos K; Steiner T; Michel P
    Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale.
    Casaubon L; McLaughlin P; Webb G; Yeo E; Merker D; Jaigobin C
    Can J Neurol Sci; 2007 Feb; 34(1):74-80. PubMed ID: 17352351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of patent foramen ovale closure versus medical therapy for prevention of recurrent ischemic neurological events: Impact of medication type.
    Pan X; Xu L; Zhou C; Zhang Z; Sun H
    Medicine (Baltimore); 2021 Jun; 100(25):e26473. PubMed ID: 34160457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke subtypes and interventional studies for transient ischemic attack.
    Lavallée P; Amarenco P
    Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
    Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL
    Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.
    McCabe DJ; Rakhit RD
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):14-24. PubMed ID: 17172564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.
    Block PC; Burstein S; Casale PN; Kramer PH; Teirstein P; Williams DO; Reisman M
    JACC Cardiovasc Interv; 2009 Jul; 2(7):594-600. PubMed ID: 19628179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020.
    Gladstone DJ; Lindsay MP; Douketis J; Smith EE; Dowlatshahi D; Wein T; Bourgoin A; Cox J; Falconer JB; Graham BR; Labrie M; McDonald L; Mandzia J; Ngui D; Pageau P; Rodgerson A; Semchuk W; Tebbutt T; Tuchak C; van Gaal S; Villaluna K; Foley N; Coutts S; Mountain A; Gubitz G; Udell JA; McGuff R; Heran MKS; Lavoie P; Poppe AY;
    Can J Neurol Sci; 2022 May; 49(3):315-337. PubMed ID: 34140063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peri-device leakage not CHA2DS2-VASc is associated with post-left atrial appendage closure cardiovascular event.
    Huang PS; Chiu FC; Cheng HL; Hsu JC; Chua SK; Chu CY; Lin TT; Chen JJ; Tsai CT
    J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106688. PubMed ID: 36095860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events.
    Alperi A; Guedeney P; Horlick E; Nombela-Franco L; Freixa X; Pascual I; Mesnier J; Houde C; Abrahamyan L; Montalescot G; Rodés-Cabau J
    Circ Cardiovasc Interv; 2022 Jul; 15(7):e011652. PubMed ID: 35735021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry.
    Yoshimoto T; Toyoda K; Ihara M; Inoue H; Yamashita T; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Maruyama H; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T
    Stroke; 2022 Aug; 53(8):2549-2558. PubMed ID: 35440169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.